D.S. FATTAKHOVA¹, F.V. VALEYEVA¹, L.R. SAFIULLINA²

¹Kazan State Medical University, 49 Butlerov St., Kazan, Russian Federation, 420012

²Kazan State Medical Academy, 11 Mushtari St., Kazan, Russian Federation, 420012

Fattakhova D.S. — postgraduate student of the Department of Hospital Therapy, tel.: +7-905-0-26-46-48, (843) 236-13-51, e-mail: fdinara@mail.ru

Valeyeva F.V. — D. Med. Sc., Professor of the Department of Hospital Therapy, tel. (843) 236-13-51, e-mail: val-farida@yandex.ru

Safiullina L.R. — Cand. Med. Sc., Associate Professor of the Department of Ultrasound Diagnostics, (843) 233-34-88, e-mail: lsaf66@mail.ru³

Diabetic gastroparesis is a disorder that occurs in both type 1 and type 2 diabetes mellitus, characterized by abnormal gastric function resulting in delayed gastric emptying in the absence of mechanical obstruction. The article summarizes the literature data on diabetic gastroparesis published in the recent 10 years. The epidemiology, pathogenesis, diagnosis and treatment of diabetic gastroparesis are examined. The new opportunities for early diagnostics and targeted therapy are highlighted.

Key words: diabetic gastroparesis, diabetes mellitus, pathogenesis.

 

 

REFERENCES

1. Kassander P. Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann. Intern. Med., 1958, no. 348, pp. 797-812.

2. Bytzer P., Talley NJ., Leemon M. et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch. Intern. Med., 2001, no. 161, rr. 1989-1996.

3. Jung H., Choung R., Locke G. et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology, 2009, no. 136, rr. 1225-1233.

4. Datz F., Christian P., Moore J. Gender-related differences in gastric emptying. J. Nucl. Med., 1987, no. 28, rr. 1204-1207.

5. Soykan I., Sivri B., Sarosiek I. et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig. Dis. Sci., 1998, no. 43, pp. 2398-2404.

6. Jones K., Russo A., Stevens J. et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care, 2001, no. 24, rr. 1264-9.

7. Camilleri M. Integrated upper gastrointestinal response to food intake. Gastroenterology, 2006, no. 131, rr. 640-658.

8. Fraser R., Horowitz M., Dent J. Hyperglycaemia stimulates pyloric motility in normal subjects. Gut, 1991, no. 32, pp. 475–478.

9. Jebbink R., Samsom M., Bruijs P. et al. Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with type I diabetes mellitus. Gastroenterology, 1994, 107, pp. 1390-1397.

10. Jones K., Berry M., Kong M. et al. Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects. Diabetes Care, 1999, no. 22, rr. 339-344.

11. Lysy J., Israeli E., Strauss-Liviatan N. et al. Relationships between hypoglycaemia and gastric emptying abnormalities in insulin-treated diabetic patients. Neurogastroenterol. Motil., 2006, no. 18, rr. 433-440.

12. Ceriello A., Ihnat M. ‘Glycaemic variability’: a new therapeutic challenge in diabetes and the critical care setting. Diabet. Med., 2010, vol. 27, no. 8, rr. 862-867.

13. Monnier L., Colette C. Glycemic Variability: The Third Component of the Dysglycemia in Diabetes. Is It Important? How to Measure It? J. Diabetes. Sci. Technol., 2008, vol. 2, no. 6, rr. 1094-1100.

14. The Diabetes Control and Complications Trial Research Group 1995 The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes, 1995, no. 44, rr. 968–983.

15. Kilpatrick E., Rigby A., Atkin S. Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control. Clin. Chem., 2007, no. 53, rr. 897-901

16. Kilpatrick E., Rigby A., Atkin S. A1c variability and the risk of microvascular complications in type 1 diabetes: data from the DCCT. Diabetes Care, 2008, no. 31, rr. 2198-2202.

17. Bragd J., Adamson U., Bäcklund L. et al. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes Metab., 2008, no. 34, rr. 612-616

18. Ishiguchi T., Nakajima M., Sone H. et al. Gastric distension-induced pyloric relaxation: central nervous system regulation and effects of acute hyperglycaemia in the rat. J. Physiol., 2001, no. 533, pp. 801-813.

19. Kniel P., Junker U., Perrin I. et al. Varied effects of experimental diabetes on the autonomic nervous system of the rat. Lab. Invest., 1986, no. 54, rr. 523-530.

20. Carroll S., Byer S., Dorsey D. et al. Ganglion-specific patterns of diabetes-modulated gene expression are established in prevertebral and paravertebral sympathetic ganglia prior to the development of neuroaxonal dystrophy. J. Neuropathol. Exp. Neurol., 2004, no. 63, rr. 1144-1154.

21. Shah V., Lyford G., Gores G. et al. Nitric oxide in gastrointestinal health and disease. Gastroenterol., 2004, no. 126, rr. 903-913.

22. Wrzos H., Cruz A., Polavarapu R. et al. Nitric oxide synthase (NOS) expression in the myenteric plexus of streptozotocin-diabetic rats. Dig. Dis. Sci., 1997, no. 42, rr. 2106-2110.

23. Farrugia G. Interstitial cells of Cajal in health and disease. Neurogastroenterol. Motil., 2008, no. 20, pp. 54-63.

24. Wang X., Huizinga J., Diamond J. et al. Loss of intramuscular and submuscular interstitial cells of Cajal and associated enteric nerves is related to decreased gastric emptying in streptozotocininduced diabetes. Neurogastroenterol. Motil., 2009, no. 21, pp. 1095-1092.

25. Iwasaki H., Kajimura M., Osawa S. et al. A deficiency of gastric interstitial cells of Cajal
accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus. J. Gastroenterol., 2006, no. 41, pp. 1076-87.

26. Chen J., Lin Z., Pan J. et al. Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis. Dig. Dis. Sci., 1996, no. 41, pp. 1538-1545.

27. Choi K., Gibbons S., Nguyen T. et al. Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterol., 2008, no. 135, rr. 2055-2064.

28. Choi K., Kashyap P., Dutta N. et al. CD206 positive M2 macrophages expressing HO1 protect against the development of delayed GE in a mouse model of diabetic gastroparesis. Gastroenterol., 2010, no. 12, rr. 120-125.

29. Lurken M., Parkman H., Abell T. et al. Histological changes in idiopathic and diabetic
Gastroparesis. Neurogastroenterol. Motil., 2009, no. 21, rr. 74.

30. Cassilly D., Kantor S., Knight L. et al. Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol. Motil., 2008, no. 20, rr. 311-339.

31. Tefera S., Gilja O., Olafsdottir E. et al. Intragastric maldistribution of a liquid meal in patients with reflux oesophagitis assessed by three dimensional ultrasonography. Gut, 2002, no. 50, rr. 153-158.

32. Revicki D., Rentz A., Dubois D. et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment. Pharmacol. Ther., 2003, no. 18, rr. 141-150.

33. McCallum R., Valenzuela G., Polepalle S. et al. Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics. J. Pharmacol. Exp. Ther., 1991, no. 258, rr. 136-142.

34. McCallum R., Cynshi O. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis – a randomized, multicentre, placebo-controlled study. Aliment. Pharmacol. Ther., 2007, no. 26, pp. 1121-1130.

35. McCallum R., Dusing R., Sarosiek I. et al. Mechanisms of symptomatic improvement after gastric electrical stimulation in gastroparetic patients. Neurogastroenterol. Motil., 2010, no. 22, rr. 161-167.